A randomized, placebo-controlled study of the NS5B inhibitor beclabuvir with peginterferon/ribavirin for HCV genotype 1

H. Tatum, P. J. Thuluvath, E. Lawitz, C. Martorell, M. Demicco, S. Cohen, V. Rustgi, N. Ravendhran, R. Ghalib, J. Hanson, J. Zamparo, J. Zhao, E. Cooney, M. Treitel, E. Hughes

Research output: Contribution to journalArticlepeer-review

16 Scopus citations

Fingerprint

Dive into the research topics of 'A randomized, placebo-controlled study of the NS5B inhibitor beclabuvir with peginterferon/ribavirin for HCV genotype 1'. Together they form a unique fingerprint.

Medicine and Dentistry

Nursing and Health Professions

Pharmacology, Toxicology and Pharmaceutical Science

Immunology and Microbiology

Biochemistry, Genetics and Molecular Biology